97 related articles for article (PubMed ID: 10530936)
1. Synthesis of heparin-like antithrombotics having perphosphorylated thrombin binding domains.
Buijsman RC; Basten JE; Dreef-Tromp CM; van der Marel GA; van Boeckel CA; van Boom JH
Bioorg Med Chem; 1999 Sep; 7(9):1881-90. PubMed ID: 10530936
[TBL] [Abstract][Full Text] [Related]
2. Experimental proof for the structure of a thrombin-inhibiting heparin molecule.
Petitou M; Imberty A; Duchaussoy P; Driguez PA; Ceccato ML; Gourvenec F; Sizun P; Hérault JP; Pérez S; Herbert JM
Chemistry; 2001; 7(4):858-73. PubMed ID: 11288878
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of synthetic heparin-like conjugates comprising different thrombin binding domains.
Basten JE; Dreef-Tromp CM; de Wijs B; van Boeckel CA
Bioorg Med Chem Lett; 1998 May; 8(10):1201-6. PubMed ID: 9871735
[TBL] [Abstract][Full Text] [Related]
4. Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.
Danishefsky I; Ahrens M; Klein S
Biochim Biophys Acta; 1977 Jun; 498(1):215-22. PubMed ID: 560216
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of a novel synthetic NAPAP-penta-saccharide conjugate displaying a dual antithrombotic action.
Buijsman RC; Basten JE; van Dinther TG; van der Marel GA; van Boeckel CA; van Boom JH
Bioorg Med Chem Lett; 1999 Jul; 9(14):2013-8. PubMed ID: 10450972
[TBL] [Abstract][Full Text] [Related]
6. SR123781A, a synthetic heparin mimetic.
Herbert JM; Hérault JP; Bernat A; Savi P; Schaeffer P; Driguez PA; Duchaussoy P; Petitou M
Thromb Haemost; 2001 May; 85(5):852-60. PubMed ID: 11372679
[TBL] [Abstract][Full Text] [Related]
7. Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin.
Mourier PA; Guichard OY; Herman F; Viskov C
Anal Biochem; 2014 May; 453():7-15. PubMed ID: 24561026
[TBL] [Abstract][Full Text] [Related]
8. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
9. Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III--thrombin complex.
Andersson LO; Engman L; Henningsson E
J Immunol Methods; 1977; 14(3-4):271-81. PubMed ID: 557071
[TBL] [Abstract][Full Text] [Related]
10. Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity.
Grootenhuis PD; Westerduin P; Meuleman D; Petitou M; van Boeckel CA
Nat Struct Biol; 1995 Sep; 2(9):736-9. PubMed ID: 7552742
[TBL] [Abstract][Full Text] [Related]
11. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
Fan B; Turko IV; Gettins PG
Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
[TBL] [Abstract][Full Text] [Related]
12. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.
Rezaie AR; Olson ST
Biochemistry; 2000 Oct; 39(39):12083-90. PubMed ID: 11009624
[TBL] [Abstract][Full Text] [Related]
13. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site.
Petitou M; Casu B; Lindahl U
Biochimie; 2003; 85(1-2):83-9. PubMed ID: 12765778
[TBL] [Abstract][Full Text] [Related]
14. Interaction of heparin with thrombin and antithrombin III.
Feinman RD; Li EH
Fed Proc; 1977 Jan; 36(1):51-5. PubMed ID: 830556
[No Abstract] [Full Text] [Related]
15. Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparin.
Sisu E; Tripathy S; Mallet JM; Driguez PA; Hérault JP; Sizun P; Herbert JM; Petitou M; Sinay P
Biochimie; 2003; 85(1-2):91-9. PubMed ID: 12765779
[TBL] [Abstract][Full Text] [Related]
16. A fragment of antithrombin that binds both heparin and thrombin.
Rosenfeld L; Danishefsky I
Biochem J; 1986 Aug; 237(3):639-46. PubMed ID: 3800906
[TBL] [Abstract][Full Text] [Related]
17. Effect of collagen on thrombin inactivation by antithrombin-III and heparin.
Blaskó G; Bédi J; Machovich R; Pálos LA
Haematologia (Budap); 1977; 11(1-2):163-8. PubMed ID: 615087
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of thrombin-inhibiting heparin mimetics without side effects.
Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
Nature; 1999 Apr; 398(6726):417-22. PubMed ID: 10201371
[TBL] [Abstract][Full Text] [Related]
19. The role of Arg46 and Arg47 of antithrombin in heparin binding.
Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
[TBL] [Abstract][Full Text] [Related]
20. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
